Recent Updates
Recently added Catalysts
ZTS Positive Sentiment

Zoetis Receives FDA Approval for Convenia® RTU for Dogs (cefovecin injectable suspension), Helping More Medium and Large Dogs Access Single-Injection Treatment

Key Takeaway: Zoetis has received FDA approval for Convenia RTU for Dogs, an injectable suspension that provides up to 14 days of antibiotic treatment for susceptible bacterial skin infections. This single-dose treatment is designed to help more medium and large dogs access effective care. The approval marks a significant advancement in animal health.

Market Sentiment Analysis

POSITIVE FACTORS

  • FDA approval for Convenia RTU for Dogs
  • Single-injection treatment for medium and large dogs
  • Effective for up to 14 days of antibiotic treatment

Full Press Release Details

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Convenia RTU for Dogs provides up to 14 days of antibiotic treatment in a single dose for susceptible bacterial skin infections

Frequently Asked Questions

What is Convenia RTU for Dogs?

Convenia RTU is an injectable antibiotic treatment for bacterial skin infections.

How long does Convenia RTU last?

It provides up to 14 days of antibiotic treatment in a single dose.

Who can benefit from Convenia RTU?

Medium and large dogs with susceptible bacterial skin infections can benefit.

What company developed Convenia RTU?

Convenia RTU was developed by Zoetis.

Last updated: Oct 20, 2026